Cambridge Team Uses AI to Aid Cancer Drug Development

AI is increasingly playing a part in the drug development process, with a common use case being to deploy it to sift through vast quantities of data to find potential avenues for exploration. A similar system has recently been developed by a team from the University of Cambridge to help scientists search for cancer-related discoveries.

The system, which is known as LION LBD, has been documented in a recently published paper, takes a different approach to many such tools, in that the data if sifts through is not so much medical data as scientific literature. The researchers reason that the literature is so vast that scientists struggle to keep up with it.